Hepatitis C virus (HCV) is highly efficient in establishing a chronic infection, having evolved multiple strategies to suppress the host antiviral responses. The HCV nonstructural 5A (NS5A) protein, in addition to its role in viral replication and assembly, has long been known to hamper the interferon (IFN) response. However, the mechanism of this inhibitory activity of NS5A remains partly characterized. In a functional proteomic screening carried out in HCV replicon cells, we identified the mitochondrial protein LRPPRC as an NS5A binding factor. Notably, we found that downregulation of LRPPRC expression results in a significant inhibition of HCV infection, which is associated with an increased activation of the IFN response. Moreover, we showed that LRPPRC acts as a negative regulator of the mitochondrial-mediated antiviral immunity, by interacting with mitochondrial antiviral signaling protein (MAVS) and inhibiting its association with TRAF3 and TRAF6. Finally, we demonstrated that NS5A is able to interfere with MAVS activity in a LRPPRC-dependent manner. (1-3) It is estimated that about 70 million people are chronically infected with HCV worldwide, (4) which increases, over time, their risk of developing steatohepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma.
H epatitis C virus (HCV) is highly efficient at establishing a chronic infection. (1) (2) (3) It is estimated that about 70 million people are chronically infected with HCV worldwide, (4) which increases, over time, their risk of developing steatohepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma. (5, 6) HCV employs diverse strategies to escape antiviral responses, including the alteration of interferon (IFN)-mediated pathways, inflammatory processes, the unfolded protein response, and autophagy.
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recruitment of immune cells to the infection sites. (1) In infected hepatocytes, HCV is mainly recognized by retinoic-acid inducible gene (RIG-I), a cytosolic RNA helicase that senses 5′ triphosphate and 3′ untranslated region of the HCV genome RNA with poly-U/ UC ribonucleotides. (10) Active RIG-I interacts with the mitochondrial antiviral signaling protein (MAVS; also called Cardif, IPS-1, or VISA), favoring, through multimerization, its interaction with various E3 ubiquitin ligases of the TRAF family, such as TRAF2, TRAF3, TRAF5, and TRAF6. (11) (12) (13) (14) TRAF proteins induce the expression of both type I interferons and pro-inflammatory cytokines by activating a signaling cascade involving the TBK1 and IKK kinases and the transcription factors IRF3, IRF7, and NF-κB. (15, 16) HCV is also recognized by different TLRs, which are able to detect viral nucleic acids (TLR3, TLR7, and TLR9) or viral proteins (TLR2 and TLR4). (17) Being located on the plasma membrane or endosomal compartments, TLR function is not limited to permissive cells, but also plays a major role in the activation of macrophages and dendritic cells. (17) TLR signaling pathways also rely on TRAF proteins, which are recruited on TLRs via a set of adaptors, such as TRIF, MyD88, TIRAP, or TRAM. (18) Despite the activation of immune sensors by HCV, most patients do not clear the virus during the acute infection phase and efficiently establish a chronic infection. (1, 2) A crucial role in the inhibition of the host antiviral response by HCV is played by NS3/4A, a protease/helicase protein complex that participates in viral RNA replication, polyprotein processing, and viral assembly. (19) NS3/4A is able to inhibit the RIG-I signaling pathway by cleaving MAVS, thus altering its multimerization properties. (20) (21) (22) In mitochondria, MAVS cleavage appears to be restricted at specific membrane contact sites between mitochondria and the endoplasmic reticulum (mitochondrial-associated membrane). (23) In addition, HCV NS3/4A interferes with other steps of the antiviral response, i.e., by targeting the E3 ubiquitin ligase Riplet, which is known to activate RIG-I by triggering K63-linked polyubiquitination. (24) NS3/4A also impacts on Tolllike receptors signaling by cleaving TRIF, an adaptor protein required for TLR3 and TLR4 activity. (25) Other HCV proteins are able to interfere with immune sensors. NS4B, an integral membrane protein that induces endoplasmic reticulum rearrangements where HCV replication occurs, (19) represses STING, an adaptor protein that induces type I IFNs in response to cytosolic DNA. (26, 27) NS5A is an essential component of the viral replication complex that also contributes to HCV particle assembly. (19) NS5A is a zinc metalloprotein organized into three discrete domains and an N-terminal amphipathic α-helix that anchors the protein to the site of viral replication. (28) Domain I forms a putative RNA binding groove and, together with domain II, is essential for RNA replication. (28) Domain III is dispensable for viral replication, while it is important for the generation of infectious viral particles, probably through its interaction with the HCV core protein and lipid droplets. (28) A role of NS5A in the inhibition of the antiviral response has initially been proposed based on its ability to bind and inhibit PKR, a double-stranded RNA-activated kinase that phosphorylates eIF2alpha
to inhibit protein translation initiation. (29) However, it has been recently shown that HCV infection requires the activation of PKR to repress the translation of type I interferon genes, (30) suggesting that the ability of NS5A to bind PKR may not be related to the inhibition of the IFN response. NS5A has been also reported to interact with MyD88, a major adaptor molecule in TLR signaling. (31) To better understand how the modulation of host functions by NS5A contributes to HCV life cycle, we performed a proteomic analysis of host factors interacting with NS5A in HCV replicon cells using a Tandem Affinity Purification (TAP) coupled to mass spectrometry approach. We demonstrated that NS5A binds to the mitochondrial protein LRPPRC and that this interaction contributes to the inhibition of the MAVS-regulated antiviral signaling during HCV infection.
Materials and Methods

IMMUNopReCIpItatIoN aND IMMUNoBlottINg aSSayS
Coimmunoprecipitation were performed lysing cells in lysis buffer (10 mM Tris pH 8.0, 150 mM NaCl, 10% glycerol, 0.5% n-Dodecyl β-D-maltoside; Sigma-Aldrich) complemented with protease and phosphatase inhibitors. Coimmunoprecipitation were performed with 1 mg of protein extracts from transfected cells. Protein extracts were incubated with 25 uL anti-FLAG or anti-hemagglutinin (HA) antibodies conjugated to agarose beads (Sigma-Aldrich) for 2 hours. Immunocomplexes were separated on NuPAGE Bis-Tris gel (Invitrogen) and electroblotted onto nitrocellulose (Amersham) or PVDF (Millipore) membranes. Blots were incubated with primary antibodies in 5% nonfat dry milk in phosphate-buffered saline (P4417, Sigma-Aldrich) plus 0.1% Tween20 (P2287, Sigma-Aldrich) overnight at 4°C. Detection was achieved using horseradish peroxidase conjugate secondary antibody ( Jackson Immunoresearch, West Grove, PA) and visualized with Luminata Crescendo (Millipore). Signals were acquired using Amersham Hyperfilm ECL (GE Healthcare, Waukesha, WI) or a ChemiDoc Imaging System (ChemiDoc Touch; Bio-Rad).
StatIStICal aNalySIS
Statistical analysis of PCR data was performed using unpaired, two-tailed Student t test (Excel software). Values are shown as mean +/-standard deviation of at least three independent experiments. Statistically significant differences are indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001 (Student t test). Densitometric analysis of immunoblots was performed using the Adobe Photoshop software. The control ratio was arbitrarily defined as 1.00.
Results
IDeNtIfICatIoN of NS5a INteRaCtINg pRoteINS IN HCV ReplICoN CellS
To identify host proteins that interact with NS5A in the context of viral replication, we established an HCV replicon cell line expressing a modified NS5A protein carrying a double HA-FLAG tag (HCV Rep HF) in a site of the domain III previously reported to tolerate insertions. (32) (Fig. 1A ) HCV Rep HF cells show viral protein levels and intracellular NS5A distribution similar to HCV replicon cells expressing untagged NS5A (HCV Rep) (Fig. 1B,C) .
To purify NS5A interacting proteins, a TAP approach was undertaken starting from either total protein extracts or an endoplasmic reticulum (ER)-enriched fraction, using n-Dodecyl β-D-maltoside as detergent to preserve membrane protein complexes (Fig. 1D) . Isolated protein complexes were separated by SDS-PAGE and stained with Sypro Ruby (Fig.  1E) . Gel lanes were sliced out, subjected to trypsin digestion, and analyzed by matrix-assisted laser desorption/ionization time-of-flight (TOF)/TOF mass spectrometry for protein identification.
Twenty-five proteins were identified ( Fig. 2A) , including peptides from NS3 and NS5B, suggesting that the HCV replication complex copurified with NS5A. Host proteins previously identified as NS5A interactors were detected, including VAP-A, VAP-B/C, PI4K, BIN1, GRP-78, HSC-70, MOB1B, NAP1L1, and NAP1L4. (28) Moreover, 10 NS5A binding proteins were identified: LRPPRC, FAM62A, Endoplasmin, Villin-1, Drebrin-1, Ribophorin I, OST48, Squalene Synthase, Myosin-Ib, GAPDH. The interaction of Hereafter, we report the functional characterization of interaction between NS5A and LRPPRC, a mitochondrial leucine-rich protein with multiple pentatricopeptide repeats (PPR). We decided to focus our attention on LRPPRC because this interaction was suggestive of a possible regulation of mitochondrial activity by NS5A, a property that has remained poorly explored hitherto.
NS5a INteRaCtS WItH lRppRC IN tHe MItoCHoNDRIal CoMpaRtMeNt
Because NS5A localizes mainly in the ER while LRPPRC is a protein with a mitochondrial targeting signal (MTS), we verified in which subcellular compartments this interaction takes place. To this end, HCV replicon cells expressing ER or mitochondrial fluorescent reporters were stained with antibodies specific for LRPPRC and NS5A and analyzed by confocal microscopy. As shown in Fig. 3A ,B, LRPPRC and NS5A mostly colocalize in the dots positive for the mitochondrial reporter, suggesting that their interaction occurs in the mitochondrial compartment (see arrows in the colocalization profiles).
Next, we attempted to map the protein domains of LRPPRC and NS5A that are responsible for their interaction. We generated NS5A mutants that contain only one of the three domains (D1, D2, and D3) together with the N-terminal amphipathic helix, which serves as a membrane anchor, and the C-terminal part where the HA-FLAG tags are located. When tested in a coimmunoprecipitation assay, we found that the second and the third domain of NS5A are sufficient to mediate the interaction with LRPPRC, although with lower affinity when compared with the full-length protein, whereas the first domain is dispensable (Fig.  3C) . Concerning the region of LRPPRC involved in NS5A interaction, we generated C-terminal truncated mutants lacking PPRs 15-20 and PPRs 9-20, respectively. As shown in Fig. 3D , a mutant protein containing the first eight PPRs retains the ability to bind NS5A. Conversely, LRPPRC mutants lacking the MTS mapping at the N-terminal part of the protein are unable to bind NS5A, confirming that the interaction takes place on the mitochondria.
lRppRC IS ReQUIReD foR effICIeNt HCV ReplICatIoN
The role of LRPPRC in HCV life cycle was investigated using both HCV replication and infection cell culture systems.
First, LRPPRC expression was downregulated in HCV replicon cells by using specific RNA interference oligonucleotides (siLRP) and HCV replication monitored by reverse-transcription real-time quantitative PCR (RT-qPCR) (Fig. 4A) . Results show that LRPPRCsilenced cells have reduced levels of HCV RNA. A decrease in HCV replication was also confirmed by analyzing NS5A levels by immunoblotting (Fig. 4B) .
Second, HuH7.5.1 cells were transfected with LRPPRC siRNA and, 24 hours later, infected with HCV JFH1. Intracellular and extracellular HCV RNA levels were analyzed by RT-qPCR at 24, 48, and 72 hours after infection. As reported in Fig. 4C ,D, the level of HCV replication (intracellular RNA) and the production of new viral particles (extracellular HCV RNA) were affected by LRPPRC downregulation. These data indicate that LRPPRC expression is required for an efficient HCV infection.
lRppRC IS a NegatIVe RegUlatoR of type I IfN eXpReSSIoN
Based on the observation that LRPPRC interacts with NS5A on mitochondria, we reasoned that the HEK293T cells were transfected with vectors encoding MYC-NS5A in combination with FLAG-LRPPRC mutants (see scheme in right panel). Protein extracts were prepared and subjected to immunoprecipitation using an anti-FLAG antibody. Blots were probed with FLAG or MYC antibodies.
role of LRPPRC in HCV infection could be related to its ability to control the mitochondrial-mediated antiviral response rather than to a direct contribution to the HCV replication complex.
To this end, we analyzed the activation of type I IFN response in HCV-infected cells upon LRPPRC downregulation. As shown in Fig. 4E and Supporting  Fig. S1A , the levels of IFNβ and IFNλ as well as of the IFN-stimulated genes MX1, ISG56, ISG15, and 2'-5' OAS are increased in LRPPRC-silenced HuH7.5.1 cells infected with HCV when compared with control cells. ISG induction was also confirmed at protein levels (Supporting Fig. S1B ). This effect was specific for LRPPRC because no effect on the type I IFN pathway was detected when the expression of VAP-A, a previously characterized NS5A-interacting protein required for HCV replication, (33) was silenced (Supporting Fig. S1C-F) . A role of LRPPRC in the regulation of HCV infection was also confirmed in LRPPRC mutant HuH7 cells (Supporting Fig. S2A ), obtained by means of a lentiviral CRISPR/Cas9 system, as well as in a murine model of HCV replication, the MMHD3 HCV replicon cells, (34) in which LRPPRC overexpression led to an increase in HCV replication associated with a reduced expression of ISG56 (Supporting Fig. S2B ).
lRppRC INteRaCtS WItH MaVS aND INHIBItS tHe MaVS aNtIVIRal SIgNalINg patHWay
A central role in the host antiviral response is played by the mitochondrial protein MAVS.
(13) Therefore, we investigated if LRPPRC is able to interact with MAVS and regulate its activity. HEK293T cells were transfected with a vector encoding FLAG-MAVS and protein extracts subjected to immunoprecipitation using an anti-FLAG antibody. Immunoblotting analysis of immunocomplexes shows that LRPPRC efficiently associates with MAVS (Fig. 5A) . The interaction between endogenous LRPPRC and MAVS was also confirmed in HuH7 and HCV replicon cells (Fig. 5B) . Interestingly, the presence of HCV replicon results in a moderate increase of the interaction between LRPPRC and MAVS, although the amount of mitochondrial full-length MAVS is reduced by NS3 cleavage.
We then tested whether the binding of LRPPRC with MAVS results in a modulation of its antiviral activity. To this end, the ability of MAVS to induce IFNβ and IFN-responsive gene expression was analyzed either in LRPPRC overexpressing cells or in LRPPRC-silenced cells. HuH7 cells were transfected with a MAVS encoding vector in combination with different amounts of an LRPPRC encoding vector, and the expression levels of IFNβ, ISG56, MX1, and 2'-5' OAS were analyzed by RT-qPCR. As shown in Fig. 5C and Supporting Fig. S3A,B , LRPPRC overexpression leads to the inhibition of the IFN response induced by MAVS.
Conversely, we found that the ectopic expression of MAVS activity in LRPPRC-silenced Huh7 cells leads an increased expression of IFNβ and IFN responsive genes both at RNA and protein levels ( Fig. 5D and Supporting Fig. S3C-E) . The higher activation of MAVS signaling was confirmed by analyzing the phosphorylation of TBK1, a downstream kinase playing a key role in IFN induction, as well as the phosphorylation of STAT1, a main transcription factor activated by IFN (Supporting Fig. S3F ). We also observed that LRPPRC negatively regulates the mitochondrial antiviral signaling by stimulating endogenous MAVS through transfection of 3' nontranslated RNA of HCV in HuH7 cells were analyzed in HuH7.5.1 at 24, 48, and 72 hours p.i. by RT-qPCR. Values were normalized to the levels of the housekeeping gene L34. Data represent means ± SD from triplicates. Statistically significant differences are indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001 (Student t test). Abbreviations: NI, not infected cells. p.i., post infection (Supporting Fig. S4 and S5) . A similar effect was detected by using a high-molecular-weight, synthetic analog of double-stranded RNA in HuH7.5.1 cells (Supporting Fig. S6 ), which are mutated for the RNA sensor RIG-I but have a functional RNA receptor MDA5.
(35) Furthermore, we verified that the induction of a higher antiviral response in HCV replicon cells upon LRPPRC downregulation was dependent on MAVS activity. As shown in Supporting Fig. S7 , the inhibition of MAVS expression abolished the effect of LRPPRC silencing on HCV replication and ISG gene induction, confirming that LRPPRC acts as a repressor of MAVS activity.
Finally, because LRPPRC has been reported to inhibit autophagy, (36) a major intracellular catabolic process that participates to the antiviral response, (37) we asked whether the decreased HCV replication in LRPPRC-silenced cells may also result from a potentiation of HCV-targeting autophagy. Downregulation of LRPPRC expression in HCV Rep cells led to an increased autophagy flux, as shown by comparing LC3II levels in the presence or absence of the lysosome inhibitor Bafilomycin A1 (Supporting Fig.  S8A ). However, HCV levels were not rescued by blocking the lysosomal activity (Supporting Fig. S8B ), suggesting that autophagy may have targets different from HCV in these cells.
lRppRC INteRfeReS WItH tHe INteRaCtIoN BetWeeN MaVS aND tRaf3/tRaf6
In the attempt to clarify how LRPPRC represses MAVS activity, we verified if LRPPRC is able to prevent the interaction of MAVS with upstream or downstream proteins involved in this antiviral signaling pathway. First, we tested the impact of LRPPRC expression on the binding of MAVS with RIG-I, a cytoplasmic sensor of viral RNA able to activate MAVS. (14) Coimmunoprecipitation analysis showed that LRPPRC overexpression has no major effects on the binding between MAVS and RIG-I (Fig. 6A) . We then analyzed the impact of LRPPRC overexpression on the binding of MAVS with TRAF3 and TRAF6, two downstream effectors responsible for the induction of type I IFN through the transcription factors IRF3 and NF-κB. (12) Notably, coimmunoprecipitation analysis shows that LRPPRC interferes with the interaction of MAVS with both TRAF3 and TRAF6 (Fig. 6B,C ). An impairment of the interaction between endogenous MAVS and TRAF6 proteins by LRPPRC overexpression was also observed when MAVS signaling was activated by transfecting 3' nontranslated RNA of HCV (Supporting Fig.  S9A ). Conversely, an increase of MAVS-TRAF3 interaction was observed in MAVS overexpressing cells upon LRPPRC downregulation (Supporting Fig. S9B ).
NS5a INHIBItS MaVS SIgNalINg IN a lRppRC-DepeNDeNt MaNNeR
The ability of LRPPRC to inhibit MAVS prompted us to test if NS5A is able to interfere with MAVS signaling by exploiting the antiviral function of LRPPRC.
To this end, we analyzed the impact of NS5A expression on the induction of type I IFN responsive genes triggered by MAVS. Cells were transfected with an expression vector encoding for MAVS, either alone or in combination with a vector for NS5A fIg. 5. LRPPRC interacts with MAVS and inhibits its antiviral activity. (A) HEK293T cells were transfected with a vector encoding FLAG-MAVS. Protein extracts were prepared and subjected to immunoprecipitation using an anti-FLAG antibody. Blots were probed with FLAG or LRPPRC antibodies. (B) Protein extracts prepared from HuH7 and HCV Rep cells were subjected to immunoprecipitation using an anti-MAVS antibody. Nonspecific IgGs were used as a negative control (IP Ctr). Blots were probed with MAVS or LRPPRC antibodies. (C) LRPPRC overexpression inhibits MAVS activity. HuH7 cells were transfected with a vector encoding FLAG-MAVS, alone or in combination with a vector encoding LRPPRC (LRP). RNA was extracted 48 hours after transfection and the levels of LRPPRC (upper panel), MX1 (middle panel), and IFNβ (lower panel) analyzed by RT-qPCR. Values were normalized to the levels of the housekeeping gene L34. Data represent means ± SD from triplicates. (D) LRPPRC downregulation enhances MAVS activity. HuH7 cells were transfected with an siRNA specific for LRPPRC (siLRP) or a control siRNA (siCTR). Twenty-four hours later, cells were transfected with a vector encoding FLAG MAVS. RNA was extracted after a further 48 hours and the levels of LRPPRC (upper panel), MX1 (middle panel), and IFNβ (lower panel) analyzed by RT-qPCR. Values were normalized to the levels of the housekeeping gene L34. Data represent means ± SD from triplicates. Statistically significant differences are indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001 (Student t test). (Fig. 7A) . As a positive control, the MAVS vector was also transfected together with that for NS3/4A, which is known to inhibit MAVS through proteolytic cleavage. (22) As shown in Fig. 7B -D, NS5A is able to inhibit MAVS activity to an extent similar to NS3/4A, as shown by the decreased expression of ISG56, MX1, and 2'-5' OAS. The ability of NS5A to interfere with the antiviral response appears to be specific for MAVS activity, because no significant effect was observed when ISG genes were induced by TBK1 overexpression (Supporting Fig. S10A) . Importantly, NS5A-mediated inhibition of MAVS correlates with its reduced ability to associate with TRAF3 and TRAF6, similar to what was observed in the case of LRPPRC (Fig. 7E,F and Supporting  Fig. S9A) .
Finally, we asked if the inhibition of MAVS signaling by NS5A is mediated by LRPPRC. To this end, the expression of type I IFN responsive genes was analyzed in LRPPRC-silenced cells upon transfection of MAVS and NS5A encoding vectors, either alone or in combination. Notably, we found that NS5A is incapable of inhibiting MAVS activity in LRPPRCsilenced cells (Fig. 8A-C and Supporting Fig. S10B ). Moreover, we observed that the ability of NS5A to interfere with the interaction between MAVS and TRAF3 is lost if LRRPRC expression is downregulated by means of a lentiviral CRISPR/Cas9 system (Fig. 8D) .
Altogether, these data indicate that NS5A can repress mitochondria-mediated antiviral response by interacting with LRPPRC.
Discussion
Understanding how viruses exploit host cellular machineries to ensure productive infection is crucial fIg. 6. LRPPRC interferes with the interaction of MAVS with TRAF3 and TRAF6. (A) HEK293T cells were transfected with vectors encoding FLAG MAVS and HA RIG-I, alone or in combination with a vector encoding LRPPRC. Protein extracts were subjected to immunoprecipitation using an anti-FLAG antibody. Blots were probed with FLAG, HA, or LRPPRC antibodies. (B) HEK293T cells were transfected with vectors encoding FLAG MAVS and HA TRAF3, alone or in combination with a vector encoding LRPPRC. Protein extracts were subjected to immunoprecipitation using an anti-FLAG antibody. Blots were probed with FLAG, HA, or LRPPRC antibodies. (C) HEK293T cells were transfected with vectors encoding HA MAVS and FLAG TRAF6, alone or in combination with a vector encoding MYC LRPPRC. Protein extracts were subjected to immunoprecipitation using an anti-HA antibody. Blots were probed with FLAG, HA, or MYC antibodies.
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for improving antiviral strategies and preventing viral pathogenesis. HCV is a well-characterized prototype of how relatively small viruses are able to interfere with host pathways for their benefit. (2) Here, we reported host proteins that interact with HCV NS5A in the context of viral replication. The identified proteins are likely to provide hints as to how HCV interacts with and alters host functions for its own benefit, for example, by reprogramming lipid metabolism (i.e., NS5A interaction with Squalene Synthase) or protein glycosylation (i.e., NS5A interaction with two subunits of the Oligosaccharyltransferase Complex) to sustain viral replication and particle assembly. (19, 38) In the present work, we focused our attention on the newly characterized interaction of NS5A with the mitochondrial protein LRPPRC. We found that LRPPRC is required for efficient HCV replication using both HCV replicon cells and the JFH1 infectious system. Moreover, we showed that the decrease of HCV replication observed upon LRPPRC downregulation is associated with an increased expression of IFNβ,IFNλ, and IFN-responsive genes. Prompted by the mitochondrial localization of LRPPRC, we found that LRPPRC binds to the mitochondrial antiviral signaling protein MAVS and inhibits its activity by preventing the interaction with the downstream effectors TRAF3 and TRAF6. Importantly, we showed that NS5A is also able to hamper MAVS signaling and that its inhibitory activity depends on the presence of LRPPRC.
LRPPRC is a mitochondrial factor whose mutations cause the French Canadian Leigh syndrome, an atypical form of cytochrome c oxidase (COX) deficiency. (39) At variance with other COX disorders that show specific defects in this mitochondrial respiratory complex, the stability of a large set of mitochondrial transcripts is negatively affected by LRPPRC depletion. (40) The main role of LRPPRC in the regulation of mitochondrial physiology appears to be related to its ability to bind RNA, in concert with the protein SLIRP, and to regulate its stability. (41) Effects of LRPPRC mutations are not limited to mitochondrial oxidative phosphorylation; alterations in fatty acid β-oxidation, permeability transition pore, ROS dynamics, and mitophagy have also been detected. (36, 42, 43) Although no evidence of an abnormal inflammatory state in the French Canadian Leigh syndrome has yet been reported, the enhanced sensitivity to cell death observed in this disorder could have a functional link with a dysregulated activity of MAVS.
More direct evidence pointing out a role of LRPPRC during viral infection comes from a study aimed at identifying host factors involved in human immunodeficiency virus (HIV ) infection. In this case, LRPPRC was found in association with the HIV-1 integrase and matrix proteins as well as HIV-1 nucleic acids. (44) In this regard, it will be interesting to verify whether HIV-1 proteins also interact with LRPPRC to inhibit the IFN-mediated antiviral response.
Our results unveiled a mechanism by which HCV is able to inhibit the MAVS pathway by interacting with LRPPRC. During HCV infection, MAVS has been described to be cleaved by the viral protease NS3/4A at the mitochondria-associated endoplasmic reticulum membrane and peroxisomes. (22, 23, 45) However, in vivo studies showed that MAVS cleavage is not complete and that the efficiency may vary depending on the viral genotype, (20) suggesting that other mechanisms may be adopted by HCV to halt this antiviral response.
The presence of cellular factors that negatively regulate MAVS signaling have been previously reported. (13) Among them, the mitochondrial RNA-binding, leucin-rich repeats containing protein NLRX1 interferes upstream on this pathway by fIg. 7. NS5A inhibits MAVS activity and interferes with its interaction with TRAF3 and TRAF6. (A) HuH7 cells were transfected with a vector encoding FLAG MAVS, alone or in combination with vectors encoding NS3/4A or NS5A. Protein extracts were prepared and probed with FLAG, MYC, or NS5A antibodies. GAPDH was analyzed as a loading control. (B-D) RNA was extracted from HuH7 cells transfected as described in (A) and the levels of ISG56 (B), MX1 (C), and 2'-5' OAS (D) analyzed by RT-qPCR. Values were normalized to the levels of the housekeeping gene L34. Data represent means ± SD from triplicates. Statistically significant differences are indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001 (Student t test). (E) HuH7 cells were transfected with vectors encoding FLAG MAVS and HA TRAF3, alone or in combination with a vector encoding NS5A. Protein extracts were subjected to immunoprecipitation using an anti-FLAG antibody. Blots were probed with FLAG, HA, or NS5A antibodies. (F) HuH7 cells were transfected with vectors encoding HA MAVS and FLAG TRAF6, alone or in combination with a vector encoding NS5A. Protein extracts were subjected to immunoprecipitation using an anti-HA antibody. Blots were probed with FLAG, HA, or NS5A antibodies.
preventing the interaction of RIG-I with MAVS. (46) The inhibitory antiviral activity of NLRX1 is not limited to MAVS, being also able to restrict NF-κB activation by LPS and STING-mediated type I IFN response activated by HIV-1, herpes simplex virus-1, and vaccinia virus. (47, 48) Interestingly, it has been recently shown that NLRX1 function is not limited to the regulation of antiviral pathways but also fIg. 8. NS5A requires LRPPRC to inhibit MAVS activity and interferes with its interaction with TRAF3. (A-C) HuH7 cells were transfected with a siRNA specific for LRPPRC (siLRPPRC) or a control siRNA (siCTR). Twenty-four hours later, cells transfected with a vector encoding FLAG MAVS, alone or in combination with a vector encoding NS5A. RNA was extracted after a further 48 hours and the levels of ISG56 (A), 2'-5' OAS (B) and MX1 (C) analyzed by RT-qPCR. Values were normalized to the levels of the housekeeping gene L34. Data represent means ± SD from triplicates. Statistically significant differences are indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001 (Student t test). (D) HuH7 cells were infected with a CRISPR-CAS9 lentiviral vector specific for LRPPRC (LRPPRC sgRNA) or a control sgRNA (Scrambled sgRNA), and transduced cells selected for puromycin resistance. LRPPRC sgRNA and Scramble sgRNA cells were then transfected with vectors encoding FLAG MAVS and HA TRAF3, alone or in combination with a vector encoding NS5A. Protein extracts were prepared and subjected to immunoprecipitation using an anti-FLAG antibody. Blots were probed with FLAG, HA, LRPPRC, or NS5A antibodies. GAPDH was analyzed as a loading control contributes to control mitochondrial activity preventing oxidative stress. (49) Considering the functional similarities between LRPPRC and NLRX1, it will be interesting to assess whether the two proteins act synergistically in controlling antiviral responses or whether they are differentially activated depending on the type of pathogen-associated molecular patterns.
In conclusion, we reported that LRPPRC acts as a negative regulator of MAVS-mediated type I interferon response, which is hijacked by HCV to allow efficient viral replication. These findings point to LRPPRC as a potential target for host-direct therapies to strengthen the activity of direct antiviral agents against HCV and to restrain the infection of a growing number of pathogenic flaviviruses, such as Dengue, Chikungunya, and Zika, for which antiviral drugs have yet to be developed. (50) 
